Advanced search

Vol 61, No 3 (2023)
Original paper
Published online: 2023-10-03

open access

View PDF Download PDF file
Page views 1143
Article views/downloads 871
Get Citation

Connect on Social Media

Connect on Social Media

Therapeutic effect of exosomes derived from hepatocyte-growth-factor-overexpressing adipose mesenchymal stem cells on liver injury

Liushenyan Yu1, Junchao Xue1, Yanyan Wu1, Hanyu Zhou1
DOI: 10.5603/fhc.95291
Pubmed: 37787035
Folia Histochem Cytobiol 2023;61(3):160-171.

Abstract

Adipose mesenchymal stem cell-derived exosomes (ADMSC-Exo) are a new strategy for the treatment of liver injury. However, mesenchymal stem cells (MSCs) exert therapeutic effects mainly by secreting hepatocyte growth factor (HGF). Therefore, we investigated the role of exosomes derived from ADMSC that overexpress HGF (ADMSCHGF-Exo) on liver injury.

Material and methods. ADMSCs were isolated from young BALB/c female mice. Then exosomes derived from ADMSC transfecting negative control (ADMSCNC-Exo) and HGF overexpression (ADMSCHGF-Exo) were isolated and identified by quantitative polymerase chain reaction (qPCR), flow cytometry, western blot, transmission electron microscope and Nanosight particle tracking analysis. These exosomes were injected into male mice via tail vein after inducing liver injury by administering 40% carbon tetrachloride (CCl4)-olive oil twice a week (3 mL/kg, subcutaneously) for 6 weeks. Liver injury and liver collagen fiber accumulation were determined by histopathological analysis. Then, the levels of serum liver function indexes (alanine aminotransferase, aspartate aminotransferase, albumin, total bilirubin), hepatocyte-specific markers (albumin, cytokeratin-18 and hepatocyte nuclear factor 4α), hepatic fibrosis-related proteins (α-smooth muscle actin and collagen I) and Rho GTPase (cell division cycle 42 and ras-related C3 botulinum toxin substrate 1) were determined by Enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, Western blot and qPCR.

Results. ADMSCs were identified by high expression of CD105 and CD44 molecules and low expression of CD45 and CD34. ADMSCs-Exo, ADMSCNC-Exo and ADMSCHGF-Exo transfected cells had similar expression of exosome-specific membrane proteins (CD63, CD81 and CD9). Mice with CCl4-induced liver injury exhibited abnormal serum liver function indexes, altered expression of hepatocyte-specific markers, hepatic fibrosis-related proteins and Rho GTPase protein as well as histopathological changes and collagen fiber accumulation in the liver. These changes were reversed by ADMSC-Exo, ADMSCNC-Exo and ADMSCHGF-Exo administration with ADMSCHGF-Exo displaying the most significant impact.

Conclusions. ADMSCHGF-Exo exerted a hepatoprotective effect in mice with experimental liver injury by alleviating hepatic fibrosis and restoring liver function.

Keywords: liver injuryadipose mesenchymal stem cellsHepatocyte growth factorexosomeRho GTPase

Article available in PDF format

View PDF Download PDF file

References

  1. Lin F, Chen W, Zhou J, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022; 13(3): 271.
    CrossRefPubMed
  2. Peng C, Zhou Zm, Li J, et al. CCl4-induced liver injury was ameliorated by Qi-Ge decoction through the antioxidant pathway. Evidence-Based Complementary and Alternative Medicine. 2019; 2019: 1–12.
    CrossRef
  3. Yang X, Jin Z, Lin D, et al. FGF21 alleviates acute liver injury by inducing the SIRT1-autophagy signalling pathway. J Cell Mol Med. 2022; 26(3): 868–879.
    CrossRefPubMed
  4. Hu C, Wu Z, Li L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. Int J Biol Sci. 2020; 16(5): 893–903.
    CrossRefPubMed
  5. Solodeev I, Meilik B, Volovitz I, et al. Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells. Cell Death Dis. 2018; 9(6): 695.
    CrossRefPubMed
  6. Liu H, Wei LK, Jian XF, et al. Isolation, culture and induced differentiation of rabbit mesenchymal stem cells into osteoblasts. Exp Ther Med. 2018; 15(4): 3715–3724.
    CrossRefPubMed
  7. Schmal H, Kowal JM, Kassem M, et al. Comparison of regenerative tissue quality following matrix-associated cell implantation using amplified chondrocytes compared to synovium-derived stem cells in a rabbit model for cartilage lesions. Stem Cells Int. 2018; 2018: 4142031.
    CrossRefPubMed
  8. Mikłosz A, Nikitiuk BE, Chabowski A. Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand? Obes Rev. 2022; 23(5): e13413.
    CrossRefPubMed
  9. Vij R, Stebbings KA, Kim H, et al. Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial. Stem Cell Res Ther. 2022; 13(1): 88.
    CrossRefPubMed
  10. Chang CL, Chen CH, Chiang JY, et al. Synergistic effect of combined melatonin and adipose-derived mesenchymal stem cell (ADMSC)-derived exosomes on amelioration of dextran sulfate sodium (DSS)-induced acute colitis. Am J Transl Res. 2019; 11(5): 2706–2724.
    PubMed
  11. Dong X, Shen LH, Yi Z, et al. Exosomes from adipose-derived stem cells can prevent medication-related osteonecrosis of the jaw. Med Sci Monit. 2021; 27: e929684.
    CrossRefPubMed
  12. Fang Y, Zhang Y, Zhou J, et al. Adipose-derived mesenchymal stem cell exosomes: a novel pathway for tissues repair. Cell Tissue Bank. 2019; 20(2): 153–161.
    CrossRefPubMed
  13. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019; 8(7).
    CrossRefPubMed
  14. Peng L, Chen Yu, Shi S, et al. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management. Stem Cell Res Ther. 2022; 13(1): 25.
    CrossRefPubMed
  15. Gao Z, Han X, Zhu Y, et al. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling. Cell Death Dis. 2021; 12(5): 414.
    CrossRefPubMed
  16. Wang X, Liu D, Zhang X, et al. Exosomes from adipose-derived mesenchymal stem cells alleviate sepsis-induced lung injury in mice by inhibiting the secretion of IL-27 in macrophages. Cell Death Discov. 2022; 8(1): 18.
    CrossRefPubMed
  17. Huang C, Zheng Y, Bai J, et al. Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice. J Orthop Translat. 2021; 27: 9–16.
    CrossRefPubMed
  18. Zhao Y, Ye W, Wang YD, et al. HGF/c-Met: a key promoter in liver regeneration. Front Pharmacol. 2022; 13: 808855.
    CrossRefPubMed
  19. Cheng W, Liu GP, Kong D, et al. Downregulation of miR-1224 protects against oxidative stress-induced acute liver injury by regulating hepatocyte growth factor. J Cell Biochem. 2019; 120(8): 12369–12375.
    CrossRefPubMed
  20. Kaido T, Yamaoka S, Tanaka J, et al. Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CCl4-induced acute liver injury in rats. Biochem Biophys Res Commun. 1996; 218(1): 1–5.
    CrossRefPubMed
  21. Dong Xi, Luo Y, Lu S, et al. Ursodesoxycholic acid alleviates liver fibrosis via proregeneration by activation of the ID1-WNT2/HGF signaling pathway. Clin Transl Med. 2021; 11(2): e296.
    CrossRefPubMed
  22. Rizvi F, Everton E, Smith AR, et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nat Commun. 2021; 12(1): 613.
    CrossRefPubMed
  23. Cao T, Xiao D, Ji P, et al. [Effects of exosomes from hepatocyte growth factor-modified human adipose mesenchymal stem cells on full-thickness skin defect in diabetic mice]. Zhonghua Shao Shang Za Zhi. 2022; 38(11): 1004–1013.
    CrossRefPubMed
  24. Ghoreshi ZA, Kabirifar R, Khodarahmi A, et al. The preventive effect of atorvastatin on liver fibrosis in the bile duct ligation rats via antioxidant activity and down-regulation of Rac1 and NOX1. Iran J Basic Med Sci. 2020; 23(1): 30–35.
    CrossRefPubMed
  25. Wang R, Wang X, Zhuang L. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease. Ann Hepatol. 2016; 15(2): 190–199.
    CrossRefPubMed
  26. Wang DS, Dou KF, Li KZ, et al. Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway. World J Gastroenterol. 2004; 10(2): 299–302.
    CrossRefPubMed
  27. Wells CM, Ahmed T, Masters JRW, et al. Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering. Cell Motil Cytoskeleton. 2005; 62(3): 180–194.
    CrossRefPubMed
  28. Cao Y, Tan J, Zhao H, et al. Bead-jet printing enabled sparse mesenchymal stem cell patterning augments skeletal muscle and hair follicle regeneration. Nat Commun. 2022; 13(7463).
    CrossRef
  29. Zhang Y, Yu X, Wang Z, et al. Pokeweed antiviral protein attenuates liver fibrosis in mice through regulating Wnt/Jnk mediated glucose metabolism. Saudi J Gastroenterol. 2018; 24(3): 157–164.
    CrossRefPubMed
  30. Liu M, Jia H, He Y, et al. Preventive effects of aqueous extract on high-fat diet-induced fatty liver of mice. Evid Based Complement Alternat Med. 2022; 2022: 7183471.
    CrossRefPubMed
  31. Heindryckx F, Binet F, Ponticos M, et al. Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing. EMBO Mol Med. 2016; 8(7): 729–744.
    CrossRefPubMed
  32. Zhang J, Zhou S, Zhou Yi, et al. Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. PLoS One. 2014; 9(12): e114670.
    CrossRefPubMed
  33. Hu C, Zhao L, Zhang L, et al. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020; 11(1): 377.
    CrossRefPubMed
  34. Chang YJ, Liu JW, Lin PC, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. 2009; 85(13-14): 517–525.
    CrossRefPubMed
  35. Couto BG, Goldenberg RC, da Fonseca LMB, et al. Bone marrow mononuclear cell therapy for patients with cirrhosis: a phase 1 study. Liver Int. 2011; 31(3): 391–400.
    CrossRefPubMed
  36. Spahr L, Chalandon Y, Terraz S, et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013; 8(1): e53719.
    CrossRefPubMed
  37. Satilmis B, Cicek GS, Cicek E, et al. Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis. World J Clin Cases. 2022; 10(14): 4348–4356.
    CrossRefPubMed
  38. Deng L, Liu G, Wu X, et al. Adipose derived mesenchymal stem cells efficiently rescue carbon tetrachloride-induced acute liver failure in mouse. ScientificWorldJournal. 2014; 2014: 103643.
    CrossRefPubMed
  39. Salunkhe S, Basak M, Chitkara D, et al. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance. J Control Release. 2020; 326: 599–614.
    CrossRefPubMed
  40. Zheng Y, Cui B, Sun W, et al. Potential crosstalk between liver and extra-liver organs in mouse models of acute liver injury. Int J Biol Sci. 2020; 16(7): 1166–1179.
    CrossRefPubMed
  41. Adetoro KO, Bolanle JD, Abdullahi SB, et al. In vivo antioxidant effect of aqueous root bark, stem bark and leaves extracts of Vitex doniana in CCl4 induced liver damage rats. Asian Pac J Trop Biomed. 2013; 3(5): 395–400.
    CrossRefPubMed
  42. Yoshida T, Adachi E, Nigi H, et al. Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CCl4 in cynomolgus monkeys. Pathology. 1999; 31(1): 29–35.
    CrossRefPubMed
  43. Chen Mi, Wang T, Jiang ZZ, et al. Anti-inflammatory and hepatoprotective effects of total flavonoid C-glycosides from Abrus mollis extracts. Chin J Nat Med. 2014; 12(8): 590–598.
    CrossRefPubMed
  44. Liu L, Guo H, Shao C, et al. Shugan Huoxue Huayu Fang attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting transforming growth factor-β1/Smad signaling. J Tradit Chin Med. 2022; 42(1): 65–72.
    CrossRefPubMed
  45. Idriss NK, Sayyed HG, Osama A, et al. Treatment efficiency of different routes of bone marrow-derived mesenchymal stem cell injection in rat liver fibrosis model. Cell Physiol Biochem. 2018; 48(5): 2161–2171.
    CrossRefPubMed
  46. Liu Q, Lei X, Cao Z, et al. TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell Biosci. 2022; 12(1): 58.
    CrossRefPubMed
  47. Shrestha N, Chand L, Han MK, et al. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes. Food Chem Toxicol. 2016; 93: 129–137.
    CrossRefPubMed
  48. Zhu Y, Niu M, Wang JB, et al. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019; 30(1): 47–58.
    CrossRefPubMed
  49. Chijioke O, Bawohl M, Springer E, et al. Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury. Front Med (Lausanne). 2015; 2: 20.
    CrossRefPubMed
  50. Sabry D, Mohamed A, Monir M, et al. The effect of mesenchymal stem cells derived microvesicles on the treatment of experimental CCL4 induced liver fibrosis in rats. Int J Stem Cells. 2019; 12(3): 400–409.
    CrossRefPubMed
  51. Gupta S, Sharma H, Soni N, et al. Comparative evaluation of anti-fibrotic effect of tissue specific mesenchymal stem cells derived extracellular vesicles for the amelioration of ccl4 induced chronic liver injury. Stem Cell Rev Rep. 2022; 18(3): 1097–1112.
    CrossRefPubMed
  52. Meng HF, Jin J, Wang H, et al. Recent advances in the therapeutic efficacy of hepatocyte growth factor gene-modified mesenchymal stem cells in multiple disease settings. J Cell Mol Med. 2022; 26(18): 4745–4755.
    CrossRefPubMed
  53. McElroy AK, Harmon JR, Flietstra T, et al. Human biomarkers of outcome following rift valley fever virus infection. J Infect Dis. 2018; 218(11): 1847–1851.
    CrossRefPubMed
  54. Chi CH, Liu IL, Lo WY, et al. Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. World J Gastroenterol. 2005; 11(10): 1496–1502.
    CrossRefPubMed
  55. Jiang Zz, Xia Gy, Zhang Y, et al. Attenuation of hepatic fibrosis through ultrasound-microbubble-mediated HGF gene transfer in rats. Clin Imaging. 2013; 37(1): 104–110.
    CrossRefPubMed
  56. Shams S, Mohsin S, Nasir GA, et al. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med. 2013; 11: 78.
    CrossRefPubMed
  57. Mosaddeghzadeh N, Ahmadian MR. The RHO family GTPases: mechanisms of regulation and signaling. Cells. 2021; 10(7).
    CrossRefPubMed
  58. Zheng J, Zhou H, Yang T, et al. Protective role of microRNA-31 in acetaminophen-induced liver injury: a negative regulator of c-Jun N-terminal kinase (JNK) signaling pathway. Cell Mol Gastroenterol Hepatol. 2021; 12(5): 1789–1807.
    CrossRefPubMed
  59. Chaker D, Mouawad C, Azar A, et al. Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor. Stem Cell Res Ther. 2018; 9(1): 167.
    CrossRefPubMed
  60. Zhao X, Fu J, Xu A, et al. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis. 2015; 6(5): e1751.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note